Latest News

The subdued stock price reaction suggests that TIM S.A.'s ( BVMF:TIMS3 ) strong earnings didn't offer any surprises...

The Hapvida Participações e Investimentos S.A. ( BVMF:HAPV3 ) share price has fared very poorly over the last month...

In recent weeks, global markets have faced a mix of challenges, including a tech-driven sell-off in U.S. stocks and the longest federal government shutdown on record, which has weighed heavily on investor sentiment. Despite these headwinds, small-cap stocks present intriguing opportunities for investors seeking growth potential amid broader market volatility. Identifying promising small-cap stocks often involves looking at companies with strong fundamentals that can weather economic...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

As global markets face challenges such as a record federal government shutdown and concerns over AI spending, investors are increasingly cautious about growth-oriented stocks. Amidst these broader market dynamics, the allure of penny stocks remains strong for those seeking opportunities in smaller or newer companies. While the term "penny stocks" may seem outdated, it continues to signify potential value in firms with solid financials and promising growth prospects. This article explores...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Noveon Magnetics and Solvay recently announced a multi-year supply agreement for light and heavy rare earth oxides, with Solvay providing Neodymium-Praseodymium, Dysprosium, and Terbium oxides, sourced partly from recycled materials, to support Noveon's production of permanent magnets starting in 2026. This collaboration advances a more resilient and sustainable domestic supply chain for rare earth magnets amid ongoing global supply risks and growing demand. The agreement enhances Solvay's...

Ardelyx, Inc. recently presented results from the first real-world study of XPHOZAH, its FDA-approved phosphate absorption inhibitor for adults with chronic kidney disease on dialysis, at the American Society of Nephrology's Kidney Week in Houston. This announcement shines a light on XPHOZAH’s unique mechanism of action and its role as the only phosphate absorption inhibitor in its class, potentially broadening treatment options for patients who do not respond to standard phosphate...

The market seemed underwhelmed by last week's earnings announcement from ZEAL Network SE ( ETR:TIMA ) despite the...

Universal Corporation recently reported improved second quarter and first-half fiscal 2026 results, highlighted by higher sales and net income, alongside the appointment of Tatiana Santos Godoi as Chief Human Resources Officer and Gregory A. Trojan to the Board of Directors. The company’s latest results indicate solid performance across both the Tobacco and Ingredients segments, with management signaling confidence in its ability to handle shifting market dynamics such as an anticipated...

Leonardo (BIT:LDO) has just released its third quarter and nine-month earnings, highlighting higher sales than last year but a small dip in nine-month net income. Investors are also watching a fresh partnership with Airbus and Thales, focused on Europe’s growing space sector. See our latest analysis for Leonardo. Momentum has been firmly on Leonardo’s side, with a stellar year-to-date share price return of 97.08% and a remarkable 1-year total shareholder return topping 106%. News of rising...

Wondering if Deutsche Telekom might be a hidden gem or an overrated stock? Let’s dig into whether its current share price makes sense given what’s under the hood. After recent volatility, the stock is currently trading at €27.27, with a 3.5% bump over the last week but down 6.5% year to date. This shows both short-term momentum and lingering uncertainty. In the past few weeks, Deutsche Telekom has attracted headlines with bold moves in European network expansion as well as strategic...

Insiders who bought Ondo InsurTech Plc ( LON:ONDO ) stock in the last 12 months were richly rewarded last week. The...

Key Insights C&D International Investment Group's significant public companies ownership suggests that the key...

While Johnson Matthey Plc ( LON:JMAT ) might not have the largest market cap around , it received a lot of attention...

Autolus Therapeutics recently reported its third quarter results, showing a reduction in net loss to US$79.12 million versus US$82.09 million a year ago, and announced operational advances including broad US market access for Obe-cel with 60 authorized treatment centers and a manufacturing success rate above 90%. The company is also progressing with clinical programs in pediatric ALL, lupus nephritis, and progressive multiple sclerosis, and announced leadership changes as it prepares for key...

California Resources Corporation and its carbon management business, Carbon TerraVault, recently announced a memorandum of understanding with Capital Power to jointly explore carbon capture and sequestration services for the La Paloma power facility in California, alongside Capital Power's recent refinancing activities, including a completed CA$600 million note offering and the announcement of a full redemption for its January 2026 notes. This combination of debt refinancing and a new...

Kyushu Financial Group (TSE:7180) has sparked renewed interest by executing a large share repurchase on the Tokyo Stock Exchange, in addition to raising its earnings guidance for the fiscal year ending March 2026. Both moves reflect a proactive approach to shareholder returns. See our latest analysis for Kyushu Financial Group. Kyushu Financial Group's sizable share repurchase and improved earnings outlook have certainly caught the market's attention, and that is apparent in the stock’s...

ABIVAX Société Anonyme (ENXTPA:ABVX) just shared patient-reported outcomes from its Phase 3 trial for obefazimod in adults with ulcerative colitis. These findings shed light on how patients actually experience the drug’s effects beyond clinical endpoints. See our latest analysis for ABIVAX Société Anonyme. After releasing the latest trial results and earning a spot in the Euronext 150 Index, ABIVAX Société Anonyme's stock has been on an impressive run. Momentum remains strong, with a 90-day...

PHINIA Inc.'s Audit Committee recently decided to engage Deloitte & Touche LLP as its independent registered public accounting firm for fiscal year 2026, replacing PricewaterhouseCoopers LLP after a competitive review, with the change approved on October 29, 2025. Switches in independent auditors can be closely watched as they may indicate changes in financial reporting or governance standards for a company. Given the incoming auditor transition, we’ll consider how this development could...

Hindustan Copper (NSE:HINDCOPPER) has had a great run on the share market with its stock up by a significant 40% over...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

argenx SE recently received Health Canada approval for VYVGART SC as a monotherapy for adult patients with active chronic inflammatory demyelinating polyneuropathy (CIDP), making it the first innovative CIDP treatment option in Canada in over 30 years and the first FcRn blocker approved for this use. The once-weekly, subcutaneous self-administration of VYVGART SC presents a new level of flexibility and convenience for patients while potentially reducing demand for human-derived blood...